Guidelines for quality assurance in Multicenter Trials: A position paper

Controlled Clinical Trials

Volumn 19, Issue 5, 1998, Pages 477-493

  Knatterud, Genell L ^a   Rockhold, Frank W ^b   George, Stephen L ^e   Barton, Franca B ^a   Davis, C E ^c   Fairweather, William R ^d   Honohan, Tom ^f   Mowery, Richard ^g   O'Neill, Robert ^d  

^a MARYLAND MEDICAL RESEARCH INSTITUTE   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f SANOFI   (France)

^g NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Auditing; Data integrity; Errors; Monitoring; Quality control; Scientific misconduct

Indexed keywords

CLINICAL TRIAL; COST; DATA ANALYSIS; ERROR; HUMAN; MONITORING; MULTICENTER STUDY; PRACTICE GUIDELINE; QUALITY CONTROL; REVIEW;

EID: 0032189183     PISSN: 01972456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-2456(98)00033-6     Document Type: Article

References (35)

1. Report of the Commission on Research Integrity Integrity and Misconduct in Research. 1995;U.S. Department of Health and Human Services, Washington, DC.
2. Meinert C.L. Clinical trials and data integrity. Controlled Clin Trials. 1:1980;189-192.
3. Neaton J.D., Duchene A.G., Svendsen K.H.et al. An examination of the efficiency of some quality assurance methods commonly employed in clinical trials. Stat Med. 9:1990;115-124.
4. Hill A.B. The clinical trial. Br Med Bull. 7:1951;278-282.
5. Meinert C.L. Quality assurance. Clinical Trials. Design, Conduct and Analysis:1986;Oxford University Press, New York.
6. Pollock B.H. Quality assurance for interventions in clinical trials. Multicenter data monitoring, data management, and analysis. Cancer. 74:1994;2647-2652.
7. Anonymous Clinical trial monitoring. hit or miss? Science. 264:1994;1534-1541.
8. U.S. Department of Health and Human Services, Food and Drug Administration International conference on harmonization; draft guideline on good clinical practice. Federal Register. 60(159):1995;42948-42957.
9. George S.L. Reducing patient eligibility criteria in cancer clinical trials. J Clin Oncol. 14:1996;1364-1370.
10. Fisher B., Redmond C.K. Fraud in breast-cancer trials. N Engl J Med. 330:1994;1458-1460.
11. Neaton J.D., Bartsch G.E., Broste S.K.et al. A case of data alteration in the Multiple Risk Factor Intervention Trial (MRFIT). The MRFIT Research Group. Controlled Clin Trials. 12:1991;731-740.
12. U.S. Department of Health and Human Services National Institutes of Health. Waiver of informed consent requirements in certain emergency research. Federal Register. 61(192):1996;51531-51533.
13. Jollis J.G., Ancukiewicz M., DeLong E.R.et al. Discordance of databases designed for claims payment versus clinical information systems. implications for outcomes research Ann Intern Med. 119:1993;844-850.
14. Gore J.M., Granger C.B., Simoons M.L.et al. Stroke after thrombolysis. mortality and function outcomes in the GUSTO-I trial Circulation. 92:1995;2811-2818.
15. Newby L.K., Califf R.M., Guerci A.et al. Early discharge in the thrombolytic era. an analysis of criteria for uncomplicated infarction from the global utilization of streptokinase and t-PA for occluded coronary arteries (GUSTO) trial J Am Coll Cardiol. 27:1996;625-632.
16. Weiss R.B., Vogelzang N.J., Peterson B.A.et al. A successful system of scientific data audits for clinical trials. A report from the Cancer and Leukemia Group B. JAMA. 270:1993;459-464.
17. Christian M.C., McCabe M.S., Korn E.L.et al. The National Cancer Institute audit of the National Surgical Adjuvant Breast and Bowel Project Protocol B-06. N Engl J Med. 333:1995;1469-1474.
18. Vantongelen K., Rotmensz N., Van Der Schueren E. Quality control of validity of data collected in clinical trials. Eur J Cancer Clin Oncol. 25:1989;1241-1247.
19. Randall A.M.Y., Ra K., Knatterud G.L. Auditing and verification of clinical data. a coordinating center's role Controlled Clin Trials. 17:1996;121S.
20. Blumenstein B.A. Verifying keyed medical research data. Stat Med. 12:1993;1535-1542.
21. The University Group Diabetes Program VIII. Evaluation of insulin therapy. final report Diabetes. 31(suppl 5):1982;1-81.
22. Karlowski T.R., Chalmers T.C., Frenkel L.D.et al. Ascorbic acid for the common cold. a prophylactic and therapeutic trial JAMA. 231:1975;1038-1042.
23. The TIMI Study Group Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med. 320:1989;618-627.
24. Conti C.R., Knatterud G.L., Sopko G. Correction. J Am Coll Cardiol. 26:1995;842.
25. Aiello L.M., Ferris F.L. Photocoagulation for diabetic macular edema. Arch Ophthalmol. 105:1987;1163.
26. Angell M., Kassirer J.P. Setting the record straight in the breast-cancer trials. N Engl J Med. 330:1994;1448-1450.
27. Peto R., Collins R., Sackett D.et al. The trials of Dr. Bernard Fisher. a European perspective on an American episode Controlled Clin Trials. 18:1997;1-13.
28. Fisher B., Anderson S., Redmond C.K.et al. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without radiation in the treatment of breast cancer. N Engl J Med. 333:1995;1456-1461.
29. Bailey K.R. Detecting fabrication of data in a multicenter collaborative animal study. Controlled Clin Trials. 12:1991;741-752.
30. U.S. Department of Health and Human Services, Food and Drug Administration Responsibilities of awardee and applicant institutions for dealing with and reporting possible misconduct in science. Federal Register. 54(151):1989;32446-32451.
31. Meinert C.L. Cost and related issues. Clinical Trials. Design, Conduct and Analysis:1986;Oxford University Press, New York.
32. Califf R.M., Karnosh S.L., Woodlief L.H. Developing systems for cost effective auditing of clinical trials. Controlled Clin Trials. 18:1997;651-660.
33. Peto R., Collins R., Gray R. Large-scale randomized evidence. large, simple trials and overview of trials J Clin Epidemiol. 48:1995;23-40.
34. DeMets D.L., Meinert C.L. Data integrity. Controlled Clin Trials. 12:1991;727-730.
35. Simon R., Wittes R.E. Methodologic guidelines for reports of clinical trials. Cancer Treatment Rep. 69:1985;1-3.